Omkar Pharmachem Board Meeting on Aug 13 to Approve Unaudited Results

Omkar Pharmachem Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report. The company also confirmed that the trading window for its securities will remain closed until August 15, 2026, for designated persons and their immediate relatives, in line with SEBI regulations and the company's code of conduct.